Trial Profile
A retrospective trial to investigate Tc-99m-tilmanocept (Lymphoseek) versus Tc-99m filtered sulfur colloid for sentinel lymph node visualization in fatty breasts
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Jun 2016
Price :
$35
*
At a glance
- Drugs Tc 99m tilmanocept (Primary) ; Tc 99m sulfur colloid
- Indications Breast cancer
- Focus Diagnostic use
- 22 Jun 2016 New trial record
- 16 Jun 2016 Results published in a Navidea Biopharmaceuticals media release.